Nicole Gray of BioPharma DIVE asked industry visionaries, including our Executive Chairman Hugo Stephenson MD, what they saw as the most important developments in the clinical trials industry in 2015, and what we should all be watching – and doing – this year. Among Hugo’s comments: “There will be an increased focus on the patient experience. We expect to see greater recognition that the patient is central to the clinical trials process. This change has already begun, and is being championed by groups such as CISCRP.”
You can read more here: